This Monday, there was a pivotal ruling from the U.S., which carries significant implications for the pharmaceutical industry and healthcare costs. 🔍 Case Summary: The court rejected a legal ...
Sifting through countless of stocks in the Pharmaceuticals industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about ...
- A US district court judge has found Bristol-Myers Squibb's patent on the use of Buspar (buspirone), used in the treatment of neurotic anxiety, to be invalid. Bristol-Myers and its Mead Johnson unit ...
The United States(US) Patent Office dominates the patent filings and grants with nearly 24% filings and 23% grants. The United States(US), European Patent Office(EPO), World Intellectual Property ...
Global marine fisheries are in crisis: 90 percent are fully fished and overfished. The result is lost economic benefits of approximately $83 billion a year ---the “sunken billions” of the title.
NEW: Johnson & Johnson and Bristol Myers Squibb Co.'s bids to block a government drug price-setting program were dismissed by a federal judge Monday. Another loss to the pharmaceutical industry ...
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products ...
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Breyanzi is indicated for use in FL patients who have undergone at least two previous systemic therapies. Credit: Bristol Myers Squibb/Business Wire. The US Food and Drug Administration (FDA) has ...
Johnson & Johnson (NYSE: JNJ) today announced it has completed its acquisition of Shockwave Medical. Shockwave is now part of Johnson & Johnson and will operate as a business unit within Johnson ...